Mealey's (September 14, 2021, 1:38 PM EDT) -- KANSAS CITY, Kan. — Class counsel on Sept. 10 filed a motion asking a Kansas federal judge to grant final approval of a $345 million class settlement of consumer and third-party payers claims alleging anti-competitive behavior by Pfizer Inc. and two related defendants in their marketing of the EpiPen epinephrine autoinjector....